BlackRock Advisors
NNVC icon

BlackRock Advisors’s NanoViricides NNVC Stock Holding History

BlackRock Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,055
Closed -$47K – 3731
2015
Q1 		$47K Buy
1,055
+208
+25% +$11.1K ﹤0.01% 3261
2014
Q4 		$46K Hold
847
– – ﹤0.01% 3295
2014
Q3 		$51K Hold
847
– – ﹤0.01% 3264
2014
Q2 		$72K Buy
+847
New +$60.1K ﹤0.01% 3186

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Colony Group
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock Advisors's NNVC Position: Q2 2015 in Review

BlackRock Advisors sold out of NanoViricides (NNVC) in Q2 2015, closing a stake of 1,055 shares — an estimated $47K sold.

BlackRock Advisors first reported a position in NNVC in Q2 2014 and held it in 4 quarters. The position peaked at $72K in Q2 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2015.

  • BlackRock Advisors reported no remaining NanoViricides position as of Q2 2015 after selling out during the quarter.
  • BlackRock Advisors sold 1,055 NanoViricides shares in Q2 2015, an estimated $47K.
  • BlackRock Advisors first reported a position in NanoViricides in Q2 2014 and held it in 4 quarters.
  • BlackRock Advisors's NanoViricides position peaked at $72K in Q2 2014.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2015.

Based on BlackRock Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.